Stay updated with breaking news from Nasdaq indv. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Indivior (NASDAQ:INDV – Get Free Report) and Agile Therapeutics (NASDAQ:AGRX – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends and profitability. Institutional & Insider Ownership 60.3% of Indivior shares are […] ....
Craig Hallum started coverage on shares of Indivior (NASDAQ:INDV – Free Report) in a research note published on Wednesday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $37.00 price objective on the stock. Indivior Trading Up 0.7 % Indivior stock opened at $21.59 on Wednesday. The stock has a market cap […] ....
Indivior (NASDAQ:INDV – Get Free Report) posted its quarterly earnings results on Thursday. The company reported $0.43 EPS for the quarter, topping the consensus estimate of $0.28 by $0.15, MarketWatch Earnings reports. Indivior had a negative net margin of 22.57% and a positive return on equity of 370.37%. The company had revenue of $293.00 million […] ....
Deutsche Bank AG acquired a new position in shares of Indivior PLC (NASDAQ:INDV – Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 137,901 shares of the company’s stock, valued at approximately $3,181,000. A number of other institutional investors and hedge funds […] ....
Indivior PLC (NASDAQ:INDV – Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $18.28, but opened at $17.52. Indivior shares last traded at $17.50, with a volume of 22,594 shares. Indivior Stock Down 3.7 % The company has a 50-day moving average price of $16.02 and a […] ....